Flavia Biamonte
Overview
Explore the profile of Flavia Biamonte including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
1067
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Antonelli A, Battaglia A, Sacco A, Petriaggi L, Giorgio E, Barone S, et al.
Front Oral Health
. 2024 Sep;
5:1461022.
PMID: 39296524
Oral squamous cell carcinoma (OSCC) is an aggressive disease whose incomplete biological comprehension contributes to the inappropriate clinical management and poor prognosis. Thus, the identification of new promising molecular targets...
2.
Sacco A, Battaglia A, Santamaria G, Buffone C, Barone S, Procopio A, et al.
PLoS One
. 2023 Dec;
18(12):e0293475.
PMID: 38096163
Emerging evidence shows that oral squamous cell carcinoma (OSCC) invasiveness can be attributed to a small subpopulation of cancer stem cells (CSCs) in the bulk of the tumor. However, the...
3.
Battaglia A, Giorgio E, Petriaggi L, Biamonte F, Momeny M
Front Oncol
. 2023 Dec;
13:1340318.
PMID: 38094612
No abstract available.
4.
Battaglia A, Sacco A, Vecchio E, Scicchitano S, Petriaggi L, Giorgio E, et al.
Front Cell Dev Biol
. 2023 Nov;
11:1272667.
PMID: 38033861
Detachment from the extracellular matrix (ECM) is the first step of the metastatic cascade. It is a regulated process involving interaction between tumor cells and tumor microenvironment (TME). Iron is...
5.
Di Vito A, Chiarella E, Sovereto J, Bria J, Perrotta I, Salatino A, et al.
Eur J Cell Biol
. 2023 Aug;
102(4):151354.
PMID: 37604089
Alendronate (ALN) is a second-generation bisphosphonate widely used for osteoporosis and cancer-induced bone lesions. Many studies have confirmed a strong relationship between osteonecrosis of the jaws (ONJ) development and oral...
6.
Battaglia A, Sacco A, Aversa I, Santamaria G, Palmieri C, Botta C, et al.
Front Cell Dev Biol
. 2023 Jun;
11:1208485.
PMID: 37377735
The PD-1/PD-L1 axis is hijacked by lung adenocarcinoma (LUAD) cells to escape immune surveillance. PD-L1 expression in LUAD is affected, among others, by the metabolic trafficking between tumor cells and...
7.
Rotundo S, Borelli M, Scaglione V, Lionello R, Biamonte F, Olivadese V, et al.
Clin Exp Med
. 2023 Apr;
23(7):3681-3687.
PMID: 37097384
In a convenience sample of 93 patients treated with monoclonal antibodies (moAbs) against SARS-CoV-2, the interleukin-6/lymphocyte count ratio (IL-6/LC) was able to predict clinical worsening both in early stages of...
8.
De Vitis C, Battaglia A, Pallocca M, Santamaria G, Mimmi M, Sacco A, et al.
J Exp Clin Cancer Res
. 2023 Mar;
42(1):69.
PMID: 36945054
Background: Metastases are the major cause of cancer-related morbidity and mortality. By the time cancer cells detach from their primary site to eventually spread to distant sites, they need to...
9.
Veneziano C, Marascio N, De Marco C, Quaresima B, Biamonte F, Trecarichi E, et al.
Viruses
. 2023 Feb;
15(2).
PMID: 36851622
We investigated the evolution of SARS-CoV-2 spread in Calabria, Southern Italy, in 2022. A total of 272 RNA isolates from nasopharyngeal swabs of individuals infected with SARS-CoV-2 were sequenced by...
10.
Garofalo E, Biamonte F, Palmieri C, Battaglia A, Sacco A, Biamonte E, et al.
PLoS One
. 2023 Feb;
18(2):e0281444.
PMID: 36757971
Background: Despite an apparent effective vaccination, some patients are admitted to the hospital after SARS-CoV-2 infection. The role of adaptive immunity in COVID-19 is growing; nonetheless, differences in the spike-specific...